ABT Short-Term Debt

Abbott Laboratories · Short-Term Debt

ABT logo

ABT Short-Term Debt

Latest reported$3.31B
ABT FY Short-Term Debt ($122.90M → $3.31B)
High-resolution chart · PNG

ABT short-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Short-Term Debt — Annual fiscal periods (USD)
Period endingShort-Term Debt (USD)
3,309,000,000
1,754,000,000
1,325,000,000
2,481,000,000
999,000,000
461,000,000
1,683,000,000
207,000,000
714,000,000
1,325,000,000
3,130,000,000
4,437,000,000
3,173,000,000
2,391,000,000
3,374,755,000
6,394,766,000
5,189,620,000
2,731,975,000
2,725,915,000
5,401,261,000
2,062,010,000
1,992,683,000
2,537,357,000
2,148,654,000
2,953,335,000
479,454,000
896,271,000
1,759,076,000
1,781,352,000
1,383,727,000
1,049,863,000
772,503,000
843,594,000
916,300,000
544,300,000
663,800,000
300,500,000
493,300,000
606,400,000
591,700,000
122,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.